Estónsko - estónčina - Adama

adama - suspensioonikontsentraat - asoksüstrobiin + tsüprokonasool - fungitsiidid

Estónsko - estónčina - Adama

adama - vees dispergeeruvad graanulid - metribusiin - herbitsiidid

Estónsko - estónčina - Adama

adama - suspo-emulsioon - florasulaam + fluroksüpüür - herbitsiidid

Estónsko - estónčina - Adama

adama - suspensioonikontsentraat - fludioksoniil + tebukonasool - muud tooted

Estónsko - estónčina - Adama

adama - suspensioonikontsentraat - kvinmerak + metasakloor - herbitsiidid

Estónsko - estónčina - Adama

adama - emulsioonikontsentraat - fluroksüpüür - herbitsiidid

Európska únia - estónčina - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulaarne blokaad - kõik muud ravitoimingud - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Európska únia - estónčina - EMA (European Medicines Agency)

immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastilised ained - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Estónsko - estónčina - Ravimiamet

teva b.v. - kabasitakseel - infusioonilahuse kontsentraat - 10mg 1ml 6ml 1tk

Európska únia - estónčina - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - mitu müeloomit - antineoplastilised ained - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.